ASXL1 and acute myeloid leukemia: The expression of KIAA0125 was lower in patients with t(8;21) and t(15;17) which are associated with more differentiated AML subtypes, but higher in patients with RUNX1, ASXL1 mutations, NPM1-/FLT3-ITD+ or poor-risk karyotypes.